Research Projects & Grants

For Profit Organization

  • CYTB323J12201: A Phase 2, open-label study to evaluate the efficacy and safety of rapcabtagene autoleucel in patients with active, refractory systemic lupus erythematosus (SLE) or active, refractory lupus nephritis (LN), Role: Investigator, Novartis Pharmaceuticals Corporation, (07/2026 - 07/2027) Status: Approved

Internal

  • Cardiovascular risk management in lupus nephritis and IgA nephropathy patients, Role: Investigator, LLU Dept. of Medicine, (03/2023) Status: Approved
  • Toe-brachial and ankle-brachial index and angiographically determined lower extremity arterial disease in patients with end-stage kidney disease on dialysis therapy and the respective association with subsequent amputation, Role: Investigator, LLU Dept. of Medicine, (07/2022) Status: Approved
  • Gender and Socioeconomic Disparities in Cardiovascular Events Among Patients with Nephrotic Syndrome, Role: Investigator, LLU Dept. of Medicine, (03/2025) Status: Approved
  • Personalized AI-Powered Education for Rare Glomerular Diseases and Polycystic Kidney Disease, Role: Investigator, LLU Dept. of Medicine, (02/2025) Status: Approved
  • Barriers to Plant-Based Dieting in Chronic Kidney Disease Patients, Role: Investigator, LLU Dept. of Medicine, (08/2024 - 08/2025) Status: Approved

Non-Profit Organization

  • Kidney Check: Proactive Urine Dipstick Testing in Healthy Individuals, Role: Investigator, IgAN Foundation, (07/2025) Status: Approved